Check out your Company Bowl for anonymous work chats.
At Sartorius, we are proud to have 6,205 creative and courageous women on board who are driven by our common ambition: better health for more people. From engineers to scientists to financial experts, they serve in various roles at all levels of the company - including the Executive Board. While we recognize that we are not there yet, we believe that we are making progress in the right direction. For example, the percentage of female managers below the board level increased by three percentage points again last year, reaching 47%. Find out more about diversity at our company: https://srtrs.info/fcnbg
Interview and job application tips from all around the world - now it's Neil's turn from Tokyo, Japan. Find out what he thinks it takes to make a positive first impression and what is particularly important to him during a job interview. Click here for the complete interview with more application tips on the Sartorius blog: https://srtrs.info/3e56f
At Sartorius, four generations – “Boomers”, Gen X, Y & Z – work together to find creative solutions for our customers – each bringing their own way of thinking, experience and skills to the table. Often our younger colleagues provide fresh perspectives that complement the ideas of more experienced people. Likewise, the more seasoned “masters of their craft” find ways to enhance novel ideas. And sometimes, it’s the other way around. This collaborative environment fosters continuous learning and growth, which benefits our teams and customers alike. Learn more about diversity at Sartorius on the Sartorius blog: https://srtrs.info/fcnbg
Sartorius’ Chief Financial Officer Rainer Lehmann will step down from his position by the end of October 2023 to pursue a new opportunity outside the company. The Supervisory Board of Sartorius AG has initiated a search process to identify a successor to Rainer Lehmann and to ensure a seamless transition. “Rainer Lehmann has elevated our finance organization and contributed significantly to the strategic and operational development of Sartorius,” said Dr. Lothar Kappich, Chairman of the Supervisory Board of Sartorius AG. Read Press Release: https://srtrs.info/CFO
First quarter 2023 characterized by normalization of demand After the Covid-19-related business and inventory buildup by customers had triggered strong additional growth momentum in previous years, demand normalization at the life science group Sartorius continued throughout the first quarter of 2023, as expected, and led to a decline in sales revenue and earnings in the first three months of the year. For the full year, company management continues to expect moderate growth in sales revenue and a profit margin around the high prior-year level. Read Press Release: https://lnkd.in/eWq4bM7g
Since January 2023, Adrienn has been part of Sartorius’ team in Royston, UK, as a Talent Acquisition Specialist. In this role, she’s responsible for finding the right people for open positions at local sites. Her “secret tip” for a successful job application? A well-written and structured CV because it’s the key in the application process. Get more tips for your application process from Adrienn and other recruiters from all over the world on the Sartorius blog: https://srtrs.info/p5dn0
Sartorius, through its French listed subgroup Sartorius Stedim Biotech, has signed an agreement to acquire Polyplus for approximately 2.4 billion euros. Polyplus, with around 270 employees, develops and produces #transfection as well as other DNA/RNA delivery reagents and plasmid DNA in high quality and GMP grade. These are key components in the production of viral vectors used in cell and gene therapies and other advanced medicinal therapeutic products. The proposed transaction is subject to customary conditions and expected to close during the third quarter of 2023.
Alexandra Gatzemeyer joins Executive Board of Sartorius to lead the Lab Products & Services division At today’s meeting, the Supervisory Board of Sartorius AG appointed Alexandra Gatzemeyer, Ph.D., as Member of the Executive Board, effective May 1, 2023. From June 16, 2023, Alexandra Gatzemeyer will succeed Gerry Mackay, Board Member and Head of the Lab Products & Services division, who will hand over duties in the course of May and June to ensure a smooth transition at the helm of this division. After stepping down as Executive Board member as of June 16, 2023, Gerry Mackay will continue to support Sartorius in various cross-divisional tasks and initiatives. Read Press Release: https://lnkd.in/ehbeur4v
Are you interested in one of our open positions in Sales, Services or R&D and want to learn more about Sartorius as an employer? Check out our Candidates’ Guide! https://srtrs.info/3ksai Find out what it is like to work at Sartorius and how you can advance your career with us, get the most important company information as well as our set of benefits at a glance and read more about how you can contribute to our vision of “better health for more people”.
Bringing biologics to patients takes a long way – figuratively and literally. Have you ever thought about the logistics necessary for raw materials and technologies to be in the right place at the right time? At Sartorius, the Freight Management and Distribution team tackles transport challenges every day to make sure our products reach our biopharma customers in due time and condition to produce therapies or vaccines for patients worldwide. Read more on the Sartorius blog about how they manage shipments through lockdowns, strikes or natural disasters: https://srtrs.info/i9l04
